A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Satoshi Ikeda; Hiroshige Yoshioka; Toshihiko Kaneda; Toshihide Yokoyama; Takashi Niwa; Naoyuki Sone; Tadashi Ishida; Mitsunori Morita; Hiromi Tomioka; Chihito Komaki; Masataka Hirabayashi; Yoshinori Hasegawa; Tetsuo Noguchi; Yasutaka Nakano; Chikara Sakaguchi; Kenichi Yoshimura; Toyohiro Hirai

doi:10.1159/000501967

A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Oncology ◽

10.1159/000501967 ◽

2019 ◽

Vol 97 (6) ◽

pp. 327-333

Author(s):

Satoshi Ikeda ◽

Hiroshige Yoshioka ◽

Toshihiko Kaneda ◽

Toshihide Yokoyama ◽

Takashi Niwa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research

Download Full-text

Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1910-2 ◽

2012 ◽

Vol 70 (2) ◽

pp. 271-276 ◽

Cited By ~ 8

Author(s):

Young Hak Kim ◽

Masataka Hirabayashi ◽

Yosuke Togashi ◽

Katsuya Hirano ◽

Keisuke Tomii ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Group Trial

Download Full-text

A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed, or Bevacizumab+Pemetrexed in Advanced Nonsquamous Non-Small Cell Lung Cancer (Kyoto Thoracic Oncology Research Group 1101)

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6189 ◽

2020 ◽

Author(s):

T. Kaneda ◽

H. Yoshida ◽

Y. Sakamori ◽

H. Nagai ◽

H. Ozasa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Randomized Phase Ii

Download Full-text

Phase II Study of Pemetrexed in Elderly (≥75) Non-Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group Trial 0901

Annals of Oncology ◽

10.1016/s0923-7534(20)33819-9 ◽

2012 ◽

Vol 23 ◽

pp. ix442-ix443

Author(s):

Y.H. Kim ◽

M. Hirabayashi ◽

S. Kosaka ◽

J. Nikaidoh ◽

Y. Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Group Trial

Download Full-text

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-2037-1 ◽

2013 ◽

Vol 71 (3) ◽

pp. 605-612 ◽

Cited By ~ 9

Author(s):

N. Kentepozidis ◽

A. Kotsakis ◽

A. Soultati ◽

S. Agelaki ◽

Ch. Christophylakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Multicenter Phase

Download Full-text

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

British Journal of Cancer ◽

10.1038/bjc.2017.137 ◽

2017 ◽

Vol 117 (1) ◽

pp. 8-14 ◽

Cited By ~ 12

Author(s):

F Koinis ◽

S Agelaki ◽

V Karavassilis ◽

N Kentepozidis ◽

E Samantas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Multicentre Phase ◽

Oncology Research

Download Full-text

Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79225-x ◽

2008 ◽

Vol 2008 ◽

pp. 180-181

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research

Download Full-text

Bortezomib in combination with gemcitabine (GEM) and cisplatin (CDDP) in patients with locally advanced/metastatic non-small cell lung cancer (NSCLC): A Hellenic Oncology Research Group multicenter phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e19050 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e19050-e19050

Author(s):

Sofia Agelaki ◽

Athanasios Kotsakis ◽

Emmanouil Kontopodis ◽

Nikolaos K. Kentepozidis ◽

Konstantinos N. Syrigos ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Multicenter Phase

Download Full-text

Salvage treatment of relapsed/refractory small cell lung cancer with pazopanib: A Hellenic Oncology Research Group’s (HORG) phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.8561 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 8561-8561

Author(s):

Athanasios Kotsakis ◽

Vasilis Karavasilis ◽

Sofia Agelaki ◽

Nikolaos K. Kentepozidis ◽

Stavros Peroukidis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Salvage Treatment ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research

Download Full-text

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

Journal of Chemotherapy ◽

10.1179/1973947812y.0000000050 ◽

2013 ◽

Vol 25 (1) ◽

pp. 49-55 ◽

Cited By ~ 33

Author(s):

Emmanouil Kontopodis ◽

Dora Hatzidaki ◽

Ioannis Varthalitis ◽

Nikolaos Kentepozidis ◽

Stylianos Giassas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Oncology Research

Download Full-text

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.06.007 ◽

2020 ◽

Vol 21 (6) ◽

pp. 520-526

Author(s):

Jyoti D. Patel ◽

Ju-Whei Lee ◽

David P. Carbone ◽

Henry Wagner ◽

Anil Shanker ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Research ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text